Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
NCT00141999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2012-09-27
Summary
The purpose of this study is to determine the immune response to an additional (booster) dose of hepatitis B vaccine 5-14 years after a three dose series was given
Conditions
- Hepatitis
Interventions
- BIOLOGICAL
-
hepatitis B vaccine
Sponsors & Collaborators
-
Alaska Native Medical Center
collaborator OTHER -
Centers for Disease Control and Prevention
lead FED
Principal Investigators
-
Anthony Fiore, MD · Centers for Disease Control and Prevention
Eligibility
- Min Age
- 5 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-05-31
- Primary Completion
- 2005-03-31
- Completion
- 2008-03-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy Children
NCT04439435 ·Status: UNKNOWN
-
The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students
NCT05099757 ·Status: UNKNOWN ·Phase: PHASE4
-
Hepatitis B Seroepidemiology Among Young Adults
NCT01973582 ·Status: UNKNOWN
-
Dose of Hepatitis B Vaccines in Non/Low-response Populations
NCT01564134 ·Status: COMPLETED ·Phase: NA
-
Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
NCT00142740 ·Status: COMPLETED
-
Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination
NCT05523921 ·Status: UNKNOWN
-
Antibody Response and Immune Memory 15-18 Years After HBV Vaccination
NCT00172328 ·Status: UNKNOWN ·Phase: NA
-
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission
NCT03977987 ·Status: COMPLETED
-
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836 ·Status: RECRUITING ·Phase: NA
-
Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention
NCT04030039 ·Status: UNKNOWN
-
Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China
NCT02898922 ·Status: COMPLETED ·Phase: PHASE4
-
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
NCT01163240 ·Status: COMPLETED
-
Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
NCT03864263 ·Status: UNKNOWN
-
HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg
NCT03405597 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk
NCT02901418 ·Status: UNKNOWN
-
Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus
NCT03932851 ·Status: UNKNOWN
-
Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
NCT00000580 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Long Term Efficacy of Recombinant Hepatitis B Vaccine in Nile Delta of Egypt
NCT02797782 ·Status: UNKNOWN
-
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
NCT01861613 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts
NCT02732054 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of the Hepatitis B Vaccine
NCT04540653 ·Status: UNKNOWN ·Phase: PHASE4
-
The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test
NCT01312012 ·Status: UNKNOWN ·Phase: PHASE4
-
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
NCT00168194 ·Status: COMPLETED
-
Qidong Hepatitis B Intervention Study
NCT00222664 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
NCT03231605 ·Status: UNKNOWN ·Phase: PHASE4